John D. Pfeifer

Washington University in St. Louis — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

62h-index29.0kcitations259works0.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(58), Sarcoma Diagnosis and Treatment(36), Genetic factors in colorectal cancer(23), Genomics and Rare Diseases(22), Lung Cancer Treatments and Mutations(19)

Publications259 total

Quantifizierung der Entzündungsaktivität bei Morbus Crohn und Colitis ulcerosa mittels spektralem Ultraschallverfahren
Zeitschrift für Gastroenterologie·2025
Differenzierung der Ätiologie diffuser Lebererkrankungen mittels spektraler H-Scan-Ultraschallanalyse
Zeitschrift für Gastroenterologie·2025
Differenzierung fokaler Leberläsionen mittels frequenzspezifischer Alterationen der Ultraschall-Rohdaten
Zeitschrift für Gastroenterologie·2025
Diverse case series of granulomatous peritonitis mimicking advanced ovarian cancer
Gynecologic Oncology Reports·2025Open Access
P0266 Ultrasound Spectroscopy for the detection of inflammation in inflammatory bowel disease
Journal of Crohn s and Colitis·2025Open Access
Diverse Case Series of Granulomatous Peritonitis Mimicking Advanced Ovarian Cancer
SSRN Electronic Journal·2025Open Access
Immune checkpoint markers and tumour mutation burden in Wilms tumour: a study of 59 cases
Pathology·2024· 5 citedOpen Access
Somatic Copy Number Alterations and Mutation Landscape in Before and Post-treatment Malignant Rhabdoid Tumor
Journal of Clinical and Translational Pathology·2024· 1 citedOpen Access
Table S3 from Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast Cancer
2023Open Access
Table S3 from Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast Cancer
2023Open Access
Supplementary Figures S1, S2, S3 and Tables S1, S2 from Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast Cancer
2023Open Access
Data from Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast Cancer
2023Open Access
Data from Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast Cancer
2023Open Access
Supplementary Figures S1, S2, S3 and Tables S1, S2 from Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast Cancer
2023Open Access
Comparison of gene fusion detection methods in salivary gland tumors
Human Pathology·2022· 11 cited
Exploring Sub-skeleton Trajectories for Interpretable Recognition of Sign Language
arXiv (Cornell University)·2022Open Access
Expression of Potential Biomarker Targets by Immunohistochemistry in Cervical Carcinomas
International Journal of Gynecological Pathology·2022· 4 cited
A Framework of Critical Considerations in Clinical Exome Reanalyses by Clinical and Laboratory Standards Institute
Journal of Molecular Diagnostics·2022· 7 citedOpen Access
Clinical Implications of a Targeted RNA-Sequencing Panel in the Detection of Gene Fusions in Solid Tumors
Journal of Molecular Diagnostics·2021· 15 citedOpen Access
Reference Samples to Compare Next-Generation Sequencing Test Performance for Oncology Therapeutics and Diagnostics
American Journal of Clinical Pathology·2021· 10 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Staffan Normark(7), Eric J. Duncavage(7), Margaret von Mehren(6), R. Lor Randall(6), Robert S. Benjamin(6), Marilyn M. Bui(6), Kristen N. Ganjoo(6), Martin J. Heslin(6), Sean V. McGarry(6), Richard F. Riedel(6), Haley Abel(6), Peter A. Humphrey(6), Suzanne George(5), Scott M. Schuetze(5), Jeffrey D. Wayne(5), Ernest U. Conrad(5), John M. Kane(5), Karen D. Schupak(5), Herbert S. Schwartz(5), David H. Spencer(5)